Serial Bronchoalveolar Lavage Fluid <i>Aspergillus</i> Galactomannan and Treatment Response in Invasive Pulmonary Aspergillosis
Resource type
Journal Article
Authors/contributors
- Friedman, Daniel Z P (Author)
- Theel, Elitza S (Author)
- Walker, Randall C (Author)
- Vikram, Holenarasipur R (Author)
- Razonable, Raymund R (Author)
- Vergidis, Paschalis (Author)
Title
Serial Bronchoalveolar Lavage Fluid <i>Aspergillus</i> Galactomannan and Treatment Response in Invasive Pulmonary Aspergillosis
Abstract
Abstract
We studied patients diagnosed with aspergillosis based on positive bronchoalveolar lavage (BAL) Aspergillus galactomannan (GM) who had follow-up BAL sampling within 180 days. GM trend and clinical outcome were concordant in only 60% (30/50). While useful for the initial diagnosis, BAL GM trending does not always correlate with treatment response.
Publication
Open Forum Infectious Diseases
Pages
ofae114
Date
2024-03-01
Language
en
ISSN
2328-8957
Accessed
3/10/24, 5:17 PM
Library Catalog
DOI.org (Crossref)
Citation
Friedman, D. Z. P., Theel, E. S., Walker, R. C., Vikram, H. R., Razonable, R. R., & Vergidis, P. (2024). Serial Bronchoalveolar Lavage Fluid Aspergillus Galactomannan and Treatment Response in Invasive Pulmonary Aspergillosis. Open Forum Infectious Diseases, ofae114. https://doi.org/10.1093/ofid/ofae114
ORGANISMS
DIAGNOSTICS
Link to this record